George Kumar, Senior Director of Medical Diagnostics, Pan Tumor and GI Cancers at AstraZeneca, shared a post on LinkedIn:
“ASCO and AI in Oncology: Rooted in Human-Centered Care.
Nice issue to read on.
Setting the Boundaries: ASCO Position Statements on AI Use.
The statement outlines the following six principles:
- Transparency: AI tools and applications should be transparent throughout their lifecycle.
- Informed Stakeholders: Patients and clinicians should be aware when AI is used in clinical decision-making and patient care.
- Fairness: Developers and users of AI should protect against bias in AI model design and use and ensure access to AI tools in application.
- Accountability: AI systems must comply with legal, regulatory, and ethical requirements that govern the use of data. AI developers should assume responsibility for their AI systems, their decisions, and their adherence to legal, regulatory, and ethical standards.
- Oversight and Privacy: Decision-makers should establish institutional compliance policies that govern the use of AI, including protections that guard clinician and patient autonomy in clinical decision-making and privacy of personal health information.
- Human-Centered Application: Human interaction is a fundamental element of health care delivery; AI does not eliminate the need for human interaction and should not be used as a substitute for sensitive interactions that require it.
Courtesy: 2025 American Society of Clinical Oncology (ASCO).”
More post featuring George Kumar on OncoDaily.